Litigation Details for Natural Alternatives International, Inc. v. Creative Compounds, LLC (S.D. Cal. 2016)
✉ Email this page to a colleague
Natural Alternatives International, Inc. v. Creative Compounds, LLC (S.D. Cal. 2016)
Docket | ⤷ Try a Trial | Date Filed | 2016-08-24 |
Court | District Court, S.D. California | Date Terminated | 2017-11-29 |
Cause | 28:1391 Venue | Assigned To | Marilyn L. Huff |
Jury Demand | Both | Referred To | Andrew G. Schopler |
Parties | CORE SUPPLEMENT TECHNOLOGIES, INC.; CREATIVE COMPOUNDS, LLC; DOES 1-100; HONEY BADGER, LLC; MYOPHARMA, INC.; NATURAL ALTERNATIVES INTERNATIONAL, INC.; NELSON NOLTE | ||
Patents | RE45,313; RE45,323; RE45,573; RE45,822 | ||
Attorneys | Caroline C. Maxwell; Frederick William Kosmo , Jr.; Hubert Kim; John K. Buche; Kevin John OShea; Kevin M Bell; Melissa Lynn Bustarde; Micah L. Bailey; Nelson Nolte; Richard J. Oparil; Scott A.M. Chambers; William John McKeague | ||
Firms | Buche & Associates, P.C.; Mayfield and Associates; Nolte Law Firm; OShea Law LLC; Porzio, Bromberg & Newman P.C.; Porzio, Bromberg and Newman, PC; Purdy and Bailey; Wilson Petty Kosmo and Turner; Wilson Turner Kosmo LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Natural Alternatives International, Inc. v. Creative Compounds, LLC
Biologic Drugs cited in Natural Alternatives International, Inc. v. Creative Compounds, LLC
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Natural Alternatives International, Inc. v. Creative Compounds, LLC (S.D. Cal. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-07-19 | 83 | asserting U.S. Patent NO. RE45,947 (“the ‘947 patent”) in the Hi-Tech case but that patent is not asserted…‘084 11 patent”), U.S. Patent No. 7,504,376 (“the ‘376 patent”), and U.S. Patent No. 5,965,596 12 …invalidated the ‘596 patent, the ‘376 patent and the ‘084 16 patent as being directed to patent ineligible subject…five beta-alanine 10 patents owned by NAI. Three of these patents— U.S. Patent No. 7,825,084 (“the ‘084…and 10 of U.S. Patent No. 8,993,610 19 (“the ‘610 patent”). The ‘865 and ‘610 patents are in the same | External link to document | |
2017-08-14 | 85 | that the ‘596, ‘376 and 11 ‘084 patents (and U.S. Patent No. RE45,947, which is not at issue here) were…ICN Pharms., Inc., 313 15 F.Supp.2d 405, 410-11 (D. Del. 2004) (finding patentable weight for functional… five patents – U.S. Patent Nos. 5,965,596 6 (“the ‘596 patent”), 7,504,376 (“the ‘376 patent”), 7,…five NAI patents asserted against Creative here – the ‘596 patent, 8 ‘376 patent, ‘084 patent, ‘610 patent… (“the ‘084 patent”), 7 8,993,610 (“the ‘610 patent”), and 8,470,865 (“the ‘865 patent”). See First | External link to document | |
2017-09-05 | 89 | alleges infringement 12 of U.S. Patent Nos. 5,965,596, 7,825,084, RE45,947, 8,993,610, and 8,470,865. …per day for at least 14 days. 4 U.S. Patent No. RE45,947 at 16:1-11 (filed Mar. 29, 2016). The Court…the ’084 patent, the ’376 patent, the ’596 27 patent, the ’865 patent, and the ’610 patent are invalid…the ’084 patent, the ’947 patent, the ’596 patent, the ’865 patent, and the ’610 patent are invalid…, the ’084 patent, the ’947 patent, the ’376 patent, the ’596 patent, the ’865 10 patent, and the ’ | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |